Source: FinanzNachrichten

Indivumed GmbH: Indivumed and Biognosys Extend Strategic Partnership

The Partnership Will Combine Each Company's Capabilities in Omics Research to Provide Biopharma Customers with Immunopeptidomics Insights for Drug Discovery Indivumed, developer of the world's lea...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Hartmut Juhl's photo - Founder & CEO of Indivumed GmbH

Founder & CEO

Hartmut Juhl

CEO Approval Rating

82/100

Read more